Weigh-losing antidiabetic ‘Jardiance’ passed wall of the health insurance
A weight-losing antidiabetic ‘Jardiance’ will receive the health insurance benefits.
According to the industry concerned on the 18th, Boehringer Ingelheim and Lilly has recently made an agreement for the price of Jardiance(empagliflozin), a SGLT-2 inhibitor. It is expected to be listed in the he...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
